The House is considering bringing a Foreign Intelligence Surveillance Act (FISA) reauthorization bill to the floor for a vote next week that would be a cleaner reauthorization that does not include controversial provisions. However, House leadership is expected to allow for amendments during debate on the bill and the Fourth Amendment is Not For Sale Act (H.R. 4639) will most certainly be offered. NAPO strongly opposes the Fourth Amendment Is Not For Sale Act as it would produce significant public safety consequences by restricting law enforcement access to critical, publicly available investigative information that is utilized every day to combat violent and serious crimes such as murder, kidnapping, drug trafficking, human trafficking, child sexual exploitation, terrorism, and threats of mass violence.

NAPO once again pledged its support for the Improving Law Enforcement Officer Safety and Wellness Through Data Act, S. 3522, which would build on existing reporting requirements and fill data gaps to increase our understanding of the circumstances precipitating and involving ambush-style attacks against law enforcement. 

The national security supplemental that is currently advancing through the Senate includes the Fentanyl Eradication and Narcotics Deterrence (FEND) Off Fentanyl Act. This bill, supported by NAPO, would help combat the country’s fentanyl crisis by enhancing current law so U.S. government agencies can more effectively disrupt illicit opioid supply chains and penalize those facilitating the trafficking of fentanyl. 

NAPO has been advocating for the House Ways & Means Committee to markup the Social Security Fairness Act, H.R. 82, to build on the momentum of the Nov. 20, 2023 field hearing. We are being told that the Committee is considering holding a hearing on the Government Pension Offset (GPO) and the Windfall Elimination Provision (WEP) in the coming weeks. You can check here to see if your Senators are cosponsors of S. 597. If they are not, please consider contacting them to urge them to cosponsor the bill. If you need any assistance, please email NAPO’s Director of Governmental Affairs Andy Edmiston at aedmiston@napo.org.

NAPO is supporting the Health Care PRICE Transparency Act 2.0 which would promote price transparency in the health care sector by requiring hospitals, insurance companies, labs, imaging providers, and ambulatory surgical centers to publicly list the prices they charge patients, empowering patients to make educated choices on the treatment and services available. 

NAPO pledged its support for the Supporting Treatment and Recovery Over Narcotics for Growth, Empowerment, and Rehabilitation (STRONGER) Act (S. 3740) which would reauthorize the Residential Substance Abuse Treatment for State Prisoners (RSAT) Grant Program under the Department of Justice’s Bureau of Justice Assistance (BJA) at $40 million a year through Fiscal Year 2029.

For more on these and other legislative issues, please click here for the Feb. 9, 2024 Washington Report.